Brief: Forward Pharma reports qtrly adj loss of per share $0.27
Sept 1 (Reuters) - Forward Pharma A/S FWP.O -
* Forward pharma reports second quarter 2016 financial and
operational results
* Q2 loss per share $0.32
* Q2 earnings per share view $-0.26 -- Thomson Reuters
I/B/E/S
* Qtrly non-GAAP loss per share $0.27
* "continue to anticipate that our rate of research and
development spending will increase in future quarters"
Source text for Eikon: ID:nGNXNACELa
Further company coverage: FWP.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA